Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-09-02

Clinical Trial Update: The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether branched-chain amino acids can improve serum albumin levels in patients with cirrhosis and ascites.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • branched-chain amino acids (branched-chain amino acids)

Snippet

Sponsor: Soonchunhyang University Hospital | Conditions: Cirrhosis, Ascites | Phase 4 | Status: UNKNOWN